Cerapedics announces commercial launch of i-FACTOR®+ Matrix in Canada for surgeries
WESTMINSTER -- Cerapedics announced the full commercial availability of i-FACTOR+ MATRIX for surgical implantation in Canada. "We are excited to announce that i-FACTOR+ Matrix is now fully... Read More
Friday November 6, 2020 0 comments
TriSalus Life Sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate
DENVER and CHICAGO -- TriSalus Life Sciences (TriSalus), an emerging immune-oncology company committed to transforming outcomes for patients with solid tumors, announced its therapeutic clinical... Read More
Monday September 28, 2020 0 comments
Maxar awarded contract to build sixth geostationary communications satellite for Intelsat in 2020
WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) today announced it will build the Galaxy 37 geostationary communications satellite for Intelsat , operator of the world’s largest... Read More
Thursday September 17, 2020 0 comments
Cerapedics announces Canadian OK of its next-generation bone graft
WESTMINSTER -- Cerapedics, a private ortho-biologics company, today announced Health Canada approval of the company's next-generation bone graft called i-FACTOR+ Matrix, making it the first market... Read More
Tuesday September 15, 2020 0 comments
McClelland joins Maxar as VP of Mission Architecture
WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) today announced it has hired space industry veteran Jim McClelland to lead its newly established Mission Architecture function. In... Read More
Thursday August 13, 2020 0 comments
Cerapedics: FDA approves company's IDE supplement
WESTMINSTER -- Cerapedics announced the U.S. Food and Drug Administration (FDA) has approved the company's Investigational Device Exemption (IDE) supplement, reducing the enrollment requirement for... Read More
Friday July 24, 2020 0 comments
Maxar renews four multi-million-dollar international defense, intel contracts
WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) today announced it renewed four contracts and expanded a fifth contract in the second quarter of 2020–together valued at more than $120... Read More
Monday July 20, 2020 0 comments
Flagship Biosciences launches new clinical diagnostics service
WESTMINSTER -- Flagship Biosciences, providers of expert tissue data insights, announced that the launch of a new clinical diagnostics immuno-oncology service, TissueInsight. TissueInsight... Read More
Monday July 6, 2020 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
